All News

The Patient-Centered Outcomes Research Institute (PCORI) has announced the approval of 50 research funding awards, totaling $30 million over two years, through its Pilot Projects Program, which will address a broad range of questions about methods for engaging patients in the health research and dissemination process.

Tecemotide, a synthetic lipopeptide immunotherapy was being developed as a cancer vaccine against the MUC1 glycoprotein that is often aberrantly overexpressed in NSCLC.

A meta-analysis published in The Lancet found that the combination was most successful in achieving the target A1C, with a minimal risk of hypoglycemia and weight loss.

Despite reported glitches, CMS plans to launch the database that will provide information on payments for research, gifts, meals, or speaker fees received by providers and teaching hospitals from the pharmaceutical industry.

A newly announced merger between Advocate Health Care and NorthShore University HealthSystem will create Illinois' largest integrated healthcare delivery system, serving 3 million patients annually.

A bill in New Jersey to regulate sober living homes points up a quandary of trying to bring resources to those struggling with addiction: too few rules can put people with mental health issues at risk. But too many could put facilities out of business, leaving even fewer places for addicts, who may have few resources, to seek care.

Retail health insurance marketplaces, also known as exchanges, are on the cusp of dramatically changing the health insurance business, according to a new report from PwC's Health Research Institute.

The study, published in BMC Medical Genomics, identified ethnicity-based variability in microRNA expression that could lead to health disparities in cancer across the globe.

The study, which evaluated the top 20 pharmaceutical companies, identified Amgen, AstraZeneca, and Celgene as the most dedicated to clinical trial data sharing.

GNS Healthcare, a leading provider of big data analytics in health care, today announced the appointment of Jan Berger, MD, MJ, to its board of directors. Berger, who served CVS Caremark as chief clinical officer for nearly 10 years, is an internationally recognized expert in medication adherence and value-based health care. She is currently president and CEO of Health Intelligence Partners, a consultancy providing business strategies and solutions to clients across the care continuum.

The panel, developed in collaboration with immunooncology scientists around the world, including at INSERM, will help researchers create a profile of the human immune response in all cancer types.

The call for all women age 30 and older to have genetic testing for the mutations that cause breast and ovarian cancer raises a host of ethical and practical concerns, to say nothing of the cost, which could run in the billions of dollars in the United States, according to a physician for a major insurer who has implemented a genetic counseling policy.

Although baby boomers are expected to place a large burden on healthcare resources, consumer health technologies could help stem increasing needs and costs, according to a new study in the Journal of Medical Internet Research.

The FDA approval will greatly influence the reach of the drug which was approved for use in advanced prostate cancer patients.

An analysis of hospital administrative costs across 8 countries found hospital bureaucracy accounts for a quarter of hospital spending in the United States.

The retrospective study, conducted at the Thomas Jefferson University in Philadelphia, found that watchful waiting among black men with early stage prostate cancer who had undergone surgery, resulted in a more aggressive disease.

US school children and especially teens are eating too much salt, and they're doing so with the staples of the American diet — things like pizza, bread, snacks, chicken nuggets, and cheeseburgers. Children ages 6-18 consumed 42 percent more sodium on average than needed, with teens consuming nearly 60 percent more than recommended levels, according to a 2009-2010 survey released yesterday by the Centers for Disease Control and Prevention.

The Health Care Cost Institute and the National Academy for State Healthy Policy are launching a grant program to fund studies that will analyze how the states are implementing health reform.

The Office of the National Coordinator for Health IT released a final rule for electronic health record certification that offers more flexibility for health information technology developers, providers, and consumers.

A joint statement by ASCO and CCO published new guidelines in the treatment of metastatic CRPC.

NICE does not deem Abraxane more effective than FOLFIRINOX, in addition to the fact that it causes severe side effects.

Extending young adults' eligibility for health insurance on their parents' plans under an Affordable Care Act provision led to a decrease in emergency department visits.

The statement points to the increased complexity of some of the LDTs and highlights patient safety issues that are at stake.

In the largest cities in 15 states plus the District of Columbia the average insurance premiums for the second-lowest-cost silver plan will decline by 0.8% in 2015, according to an analysis from the Kaiser Family Foundation.

The Department of Health and Human Services (HHS) announced it will award $60 million in Navigator grants to 90 organizations in states with federally facilitated and state partnership marketplaces.

After vowing earlier this year to find a way to expand Medicaid to 400,000 Virginians, Democratic Governor Terry McAuliffe conceded yesterday he'd been cornered by Republicans in the Legislature determined to thwart his plans. McAuliffe yesterday unveiled a modest plan to extend Medicaid to 20,000 residents with severe mental illnesses and 5,000 children of state workers.

With the objective of reducing drug abuse, especially by teenagers, the D.E.A. will now allow patients and their relatives to mail-in their unneeded stockpiles of prescription drugs back to the pharmacies.

A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type of cancer.

For patients who develop infections while staying in a hospital, the chances of it becoming drug resistant increases 1% for each day of hospitalization, according to researchers from the Medical University of South Carolina (MUSC).